Biotech Values

[DewDiligence]

Thank you, Randy, for sharing your update. Other than his unwillingness to disclose the contract manufacturer and the phase-2 trial sites, Dr. Levitt said all of the right things.

As I acknowledged in #msg-4454949, my analysis could be wrong. Nevertheless, some of Levitt’s assertions still don’t ring true for me. I guess this boils down to whether Levitt is entitled to the benefit of the doubt. Regards, Dew